LTB and neoplasm: Notably, we characterized a Treg-tumor cell-specific interaction mediated by the ligand Lymphotoxin Beta (LTB) and its receptor lymphotoxin beta receptor (LTBR), which is required for fibrosarcoma and hepatocellular carcinoma tumor formation74,75.